140 related articles for article (PubMed ID: 2872037)
1. Clinical pharmacology of polyethylene glycol-L-asparaginase.
Ho DH; Brown NS; Yen A; Holmes R; Keating M; Abuchowski A; Newman RA; Krakoff IH
Drug Metab Dispos; 1986; 14(3):349-52. PubMed ID: 2872037
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
Park YK; Abuchowski A; Davis S; Davis F
Anticancer Res; 1981; 1(6):373-6. PubMed ID: 7046623
[TBL] [Abstract][Full Text] [Related]
3. Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.
Ho DH; Wang CY; Lin JR; Brown N; Newman RA; Krakoff IH
Drug Metab Dispos; 1988; 16(1):27-9. PubMed ID: 2894951
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia].
Jürgens H; Schwamborn D; Körholz D; Wahn V; Göbel U
Klin Padiatr; 1988; 200(3):184-9. PubMed ID: 3210651
[TBL] [Abstract][Full Text] [Related]
5. L-asparaginase and PEG asparaginase--past, present, and future.
Keating MJ; Holmes R; Lerner S; Ho DH
Leuk Lymphoma; 1993; 10 Suppl():153-7. PubMed ID: 8481665
[TBL] [Abstract][Full Text] [Related]
6. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient.
Sahiner UM; Yavuz ST; Gökce M; Buyuktiryaki B; Altan I; Aytac S; Tuncer M; Tuncer A; Sackesen C
Pediatr Int; 2013 Aug; 55(4):531-3. PubMed ID: 23910807
[TBL] [Abstract][Full Text] [Related]
7. Increased antitumor activity of Escherichia coli. L-asparaginase by modification with monomethoxypolyethylene glycol.
Kamisaki Y; Wada H; Yagura T; Nishimura H; Matsushima A; Inada Y
Gan; 1982 Jun; 73(3):470-4. PubMed ID: 6751921
[TBL] [Abstract][Full Text] [Related]
8. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
[TBL] [Abstract][Full Text] [Related]
9. A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma.
Agrawal NR; Bukowski RM; Rybicki LA; Kurtzberg J; Cohen LJ; Hussein MA
Cancer; 2003 Jul; 98(1):94-9. PubMed ID: 12833461
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive properties and circulating life of Achromobacter glutaminase-asparaginase covalently attached to polyethylene glycol in man.
Abuchowski A; Davis FF; Davis S
Cancer Treat Rep; 1981; 65(11-12):1077-81. PubMed ID: 7296553
[TBL] [Abstract][Full Text] [Related]
11. Immunological responses to L-asparaginase.
Peterson RG; Handschumacher RE; Mitchell MS
J Clin Invest; 1971 May; 50(5):1080-90. PubMed ID: 4101590
[TBL] [Abstract][Full Text] [Related]
12. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of intramuscularly administered L-asparaginase.
Ho DH; Yap HY; Brown N; Benjamin RS; Friereich EJ; Blumenschein GR; Bodey GP
J Clin Pharmacol; 1981; 21(2):72-8. PubMed ID: 7229120
[TBL] [Abstract][Full Text] [Related]
14. Time Course and Management of Protracted Anaphylaxis Due to PEG-Asparaginase.
Fertal SA; Bradeen HA; Friesen E; Heath JL
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e385-e387. PubMed ID: 32815880
[TBL] [Abstract][Full Text] [Related]
15. Pegaspargase versus asparaginase in adult ALL: a pharmacoeconomic assessment.
Peters BG; Goeckner BJ; Ponzillo JJ; Velasquez WS; Wilson AL
Formulary; 1995 Jul; 30(7):388-93. PubMed ID: 10151730
[TBL] [Abstract][Full Text] [Related]
16. Pegaspargase.
Alfieri DR
Pediatr Nurs; 1995; 21(5):471-4, 490. PubMed ID: 8684851
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey.
Berg SL; Balis FM; McCully CL; Godwin KS; Poplack DG
Cancer Chemother Pharmacol; 1993; 32(4):310-4. PubMed ID: 8324873
[TBL] [Abstract][Full Text] [Related]
18. [First results of the treatment of acute leukemia with L-asparaginase].
Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
[No Abstract] [Full Text] [Related]
19. [Use of L-asparaginase in the treatment of leukosis].
Smirnov AN
Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):62. PubMed ID: 5284456
[No Abstract] [Full Text] [Related]
20. Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
O'Driscoll KF; Korus RA; Ohnuma T; Walczack IM
J Pharmacol Exp Ther; 1975 Nov; 195(2):382-8. PubMed ID: 241845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
